CNBX Pharmaceuticals Inc. filed its 10-K on Nov 30, 2022 for the period ending Aug 31, 2022. In this report its auditor, Weinstein International CPA, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.009535 USD | -6.70% | -6.86% | -33.10% |
1st Jan change | Capi. | |
---|---|---|
-33.10% | 297K | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.59% | 21.93B | |
-12.15% | 22.34B | |
-5.52% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- CNBX Stock
- News CNBX Pharmaceuticals Inc.
- CNBX Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt